Twist Bioscience (TWST) Short-term Investments (2018 - 2026)

Twist Bioscience (TWST) has reported Short-term Investments for 9 consecutive years, with $49.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 4.9% year-over-year to $49.0 million; the TTM figure through Mar 2026 stood at $49.0 million (up 4.9% YoY), while the FY2025 annual figure was $49.4 million, down 1.39% from the prior year.
• Short-term Investments fell to $49.0 million in Q1 2026 per TWST's latest filing, from $49.4 million in the prior quarter.
• Across five years, Short-term Investments topped out at $166.2 million in Q1 2022 and bottomed at $44.9 million in Q4 2023.
• Historically, Short-term Investments has averaged $72.1 million across 5 years, with a median of $49.9 million in 2023.
• Annual changes were most pronounced in 2022 — Short-term Investments soared 949.37% — and 2023, when it slumped 67.17%.
• Twist Bioscience's Short-term Investments stood at $122.0 million in 2022, then sank by 63.23% to $44.9 million in 2023, then gained by 10.14% to $49.4 million in 2024, then slipped by 0.13% to $49.4 million in 2025, then slipped by 0.73% to $49.0 million in 2026.
• Business Quant data shows TWST's Short-term Investments at $49.0 million in Q1 2026, $49.4 million in Q4 2025, and $49.4 million in Q3 2025.